457 related articles for article (PubMed ID: 19457896)
21. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187
[TBL] [Abstract][Full Text] [Related]
22. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
[TBL] [Abstract][Full Text] [Related]
23. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
Buccheri G; Ferrigno D
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
[TBL] [Abstract][Full Text] [Related]
24. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Muley T; Dienemann H; Ebert W
Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
[TBL] [Abstract][Full Text] [Related]
25. Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer.
Alifano M; Falcoz PE; Seegers V; Roche N; Schussler O; Younes M; Antonacci F; Forgez P; Dechartres A; Massard G; Damotte D; Régnard JF
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1161-7. PubMed ID: 21872279
[TBL] [Abstract][Full Text] [Related]
26. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
Muley T; Fetz TH; Dienemann H; Hoffmann H; Herth FJ; Meister M; Ebert W
Lung Cancer; 2008 Jun; 60(3):408-15. PubMed ID: 18083270
[TBL] [Abstract][Full Text] [Related]
28. Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer.
Niizeki H; Morikawa T; Okushiba S; Kondo S; Katoh H
Ann Thorac Cardiovasc Surg; 2004 Feb; 10(1):9-13. PubMed ID: 15008692
[TBL] [Abstract][Full Text] [Related]
29. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung.
Veronesi G; Pelosi G; Sonzogni A; Leon ME; D'Aiuto M; Gasparri R; De Braud F; De Pas T; Sandri M; Spaggiari L
Lung Cancer; 2005 May; 48(2):233-40. PubMed ID: 15829323
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor.
Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M
Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040
[TBL] [Abstract][Full Text] [Related]
31. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
32. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
[TBL] [Abstract][Full Text] [Related]
35. Tumor size does not have prognostic significance in stage Ia NSCLC.
Yanagi S; Sugiura H; Morikawa T; Kaji M; Okushiba S; Kondo S; Katoh H
Anticancer Res; 2000; 20(2B):1155-8. PubMed ID: 10810413
[TBL] [Abstract][Full Text] [Related]
36. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Thorac Cardiovasc Surg; 2005 Oct; 53(5):300-4. PubMed ID: 16208617
[TBL] [Abstract][Full Text] [Related]
37. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
38. Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.
Suemitsu R; Yoshino I; Tomiyasu M; Fukuyama S; Okamoto T; Maehara Y
Surg Today; 2004; 34(11):896-901. PubMed ID: 15526122
[TBL] [Abstract][Full Text] [Related]
39. [Tumor size and survival in lung cancer, stage IA].
Lyons G; Quadrelli S; Chimondegy D; Iotti A; Silva C
Medicina (B Aires); 2008; 68(1):23-30. PubMed ID: 18416316
[TBL] [Abstract][Full Text] [Related]
40. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
